Evidence map›Paper›PMID 27393218›Full record

Trial reportRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2017

A randomised controlled trial of Caphosol mouthwash in management of radiation-induced mucositis in head and neck cancer.

Kee H Wong, Aleksandra Kuciejewska, Mansour T A Sharabiani, Brian Ng-Cheng-Hin, Sonja Hoy, Tara Hurley, Joanna Rydon, Lorna Grove, Ana Santos, Motoko Ryugenji and 4 more

Open access · greenAbstract readClinical Trial, Phase IIIRandomized Controlled Trial
In one paragraph

Trial report in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 4 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 4 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Clinical relevance of the use of DentoxolWorld journal of clinical oncology · 2022
    Trial
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Interventions to improve quality of life in patients with head and neck cancers receiving radiation therapy: a scoping review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Kee H WongHead and Neck Oncology Unit, Royal Marsden Hospital, Sutton, UK; The Institute of Cancer Research, London, UK. Electronic address: kee.wong@icr.ac.uk.
Aleksandra KuciejewskaHead and Neck Oncology Unit, Royal Marsden Hospital, Sutton, UK.
Mansour T A SharabianiClinical Statistics Unit, Royal Marsden Hospital, Sutton, UK.
Brian Ng-Cheng-HinHead and Neck Oncology Unit, Royal Marsden Hospital, Sutton, UK.
Sonja HoyHead and Neck Oncology Unit, Royal Marsden Hospital, Sutton, UK.
Tara HurleyHead and Neck Oncology Unit, Royal Marsden Hospital, Sutton, UK.
Joanna RydonHead and Neck Oncology Unit, Royal Marsden Hospital, Sutton, UK.
Lorna GroveHead and Neck Oncology Unit, Royal Marsden Hospital, London, UK.
Ana SantosHead and Neck Oncology Unit, Royal Marsden Hospital, London, UK.
Motoko RyugenjiHead and Neck Oncology Unit, Royal Marsden Hospital, London, UK.
Shreerang A BhideHead and Neck Oncology Unit, Royal Marsden Hospital, Sutton, UK; The Institute of Cancer Research, London, UK.
Chris M NuttingHead and Neck Oncology Unit, Royal Marsden Hospital, London, UK; The Institute of Cancer Research, London, UK.
Kevin J HarringtonHead and Neck Oncology Unit, Royal Marsden Hospital, London, UK; The Institute of Cancer Research, London, UK.
Kate L NewboldHead and Neck Oncology Unit, Royal Marsden Hospital, Sutton, UK; The Institute of Cancer Research, London, UK. Electronic address: Kate.newbold@rmh.nhs.uk.
Royal Marsden Hospital · GBInstitute of Cancer Research · GB

Funding

Cancer Research UK 13407
6 · The paper itself

Abstract

purposeThis phase III, non-blinded, parallel-group, randomised controlled study evaluated the efficacy of Caphosol mouthwash in the management of radiation-induced oral mucositis (OM) in patients with head and neck cancer (HNC) undergoing radical (chemo)radiotherapy. PATIENTS AND

methodsEligible patients were randomised at 1:1 to Caphosol plus standard oral care (intervention) or standard oral care alone (control), stratified by radiotherapy technique and use of concomitant chemotherapy. Patients in the intervention arm used Caphosol for 7weeks: 6weeks during and 1-week post-radiotherapy. The primary endpoint was the incidence of severe OM (CTCAE ⩾grade 3) during and up to week 8 post-radiotherapy. Secondary endpoints include pharyngeal mucositis, dysphagia, pain and quality of life.

resultsThe intervention (n=108) and control (n=107) arms were well balanced in terms of patient demographics and treatment characteristics. Following exclusion of patients with missing data, 210 patients were available for analysis. The incidence of severe OM did not differ between the intervention and control arms (64.1% versus 65.4%, p=0.839). Similarly, no significant benefit was observed for other secondary endpoints. Overall, compliance with the recommended frequency of Caphosol was low.

conclusionCaphosol did not reduce the incidence or duration of severe OM during and after radiotherapy in HNC.

Indexed as

AdultAgedFemaleHead and Neck NeoplasmsHumansMaleMiddle AgedMouthwashesQuality of LifeRadiation InjuriesStomatitisMouthwashesCaphosolHead and neck cancerMucositisRadiotherapy

Identifiers

PMID27393218
PMCPMC6157713
OpenAlexW2465864453

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.